Quantitative analysis of SLC34A2 expression in different types of ovarian tumors

Experimental Oncology

Volumn 33, Issue 2, 2011, Pages 94-98

  Shyian, M ^a,b   Gryshkova, V ^b   Kostianets, O ^a,b   Gorshkov, V ^c   Gogolev, Yu ^c   Goncharuk, I ^d   Nespryadko, S ^d   Vorobjova, L ^d   Filonenko, V ^b   Kiyamova, R ^b  

^a TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^b INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^c KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

^d NATIONAL CANCER INSTITUTE   (Ukraine)

Author keywords

Gene expression; NaPi2b; Normal ovary; Ovarian cancer; SLC34A2

Indexed keywords

BIOLOGICAL MARKER; SODIUM PHOSPHATE COTRANSPORTER 2B;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY TUMOR; PAPILLARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION;

ADULT; AGED; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB; TUMOR MARKERS, BIOLOGICAL;

EID: 79959939823     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Xu H, Collins JF, Bai L, et al. Reg ulation of the human sodium-phosphate cotransporter NaPillb gene promoter by epidermal growth factor. Am J Physiol 2001; 280: 628-36.
2. Hilfiker H, Hattenhauer O, Traebert M, et al. Characterization of a new murine type II sodiumphosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 1998; 95: 14564-9. (Pubitemid 28549407)
3. Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch - Eur J Physiol 2004; 447: 763-7. (Pubitemid 38241464)
4. Gupta A, Tenenhouse H, Hoag H, et al. Identification of the type II Na+-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice. Bone 2001; 29: 467-76. (Pubitemid 33026468)
5. Giral H, Caldas Y, Sutherland E, et al. Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 2009; 297: 1466-75.
6. Feild JA, Zhang L, Brun KA, et al. Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine. Biochem Biophys Res Commun 1999; 258: 578-82. (Pubitemid 29290311)
7. Homann V, Rosin-Steiner S, Stratmann T, et al. Sodium-phosphate cotransporter in human salivary glands: molecular evidence for the involvement of NPT2b in acinar phosphate secretion and ductal phosphate reabsorption. Arch Oral Biol 2005; 50: 759-68. (Pubitemid 40817367)
8. Ikegami M, Falcone A, Whitsett JA, et al. STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury. J Appl Physiol 2008; 104: 1753-60.
9. Traebert M, Hattenhauer O, Murer H, et al. Expression of a type II sodium-phosphate cotransporter in murine type II alveolar epithelial cells. Am J Physiol 1999; 277: 868-73.
10. Huber K, Muscher A, Breves G. Sodium-dependent phosphate transport across the apical membrane of alveolar epithelium in caprine mammary gland. Comp Biochem Phys 2007; 146: 215-22. (Pubitemid 46187117)
11. Frei P, Gao B, Hagenbuch B, et al. Identification and localization of sodium-phosphate cotransporters in hepatocytes and cholangiocytes of rat liver. Am J Physiol Gastrointest Liver Physiol 2005; 288: 771-8.
12. Lundquist P, Murer P, Biber J, et al. Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate. Cell Physiol Biochem 2007; 19: 43-56.
13. Xu Y, Yeung CH, Setiawan I, et al. Sodium-inorganic phosphate cotransporter NaPi2b in the epididymis and its potential role in male fertility studied in a transgenic mouse model. Biol Reprod 2003; 69: 1135-41. (Pubitemid 37173843)
14. Yin BWT, Kiyamova R, Chua R, et al. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas; a new target for cancer immunotherapy. Cancer Immun [serial online] 2008; 8:3. URL: http://www.cancerimmunity.org/v8p3/080103.htm.
15. Mattes MJ, Look K, Furukawa K, et al. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Res 1987; 47: 6741-50. (Pubitemid 18019679)
16. Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006; 79: 650-6.
17. Huqun, Izumi S, Miyazawa H, et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 2007; 175: 263-8.
18. Yang Y, Qiao JH, An JH, et al. Detection of SLC34A2 in patients with pulmonary alveolar microlithiasis and the effect of SLC34A2 on transportation of calcium and phosphate in human alveolar epithelial cells. Zhonghua Jie He He Hu Xi Za Zhi 2008; 31: 908-11.
19. Konno Y, Moore R, Kamiya N, et al. Nuclear xenobiotic receptor PXR-null mouse exhibits hypophosphatemia and represses the Na/Pi-cotransporter SLC34A2. Pharmacogenet Genomics 2010; 20: 9-17.
20. Onishi T, Okawa R, Ogawa T, et al. Phex mutation causes the reduction of npt2b mRNA in teeth. J Dent Res 2007; 86: 158-62.
21. Kopantzev EP, Monastyrskaya GS, Vinogradova TV, et al. Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma. Lung Cancer 2008; 62: 23-34.
22. Chen DR, Chien SY, Kuo SJ, et al. SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer. Anticancer Res 2010; 30: 4135-40.
23. Galeza-Kulik M, Zebracka J, Szpak-Ulczok S, et al. Expression of selected genes involved in transport of ions in papillary thyroid carcinoma. Endokrynol Pol 2006; 57: 26-31.
24. Kim HS, Kim do H, Kim JY, et al. Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med 2010; 25: 399-407.
25. Rangel LB, Sherman-Baust CA, Wernyj RP, et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 2003; 22: 7225-32. (Pubitemid 37378555)
26. Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res 2008; 18: 538-48. (Pubitemid 351630950)
27. Auersperg N, Wong AS, Choi KC, et al. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22: 255-88. (Pubitemid 32458162)
28. Kiyamova R, Gryshkova V, Ovcharenko G, et al. Development of monoclonal antibodies specific for the human sodium-dependent phosphate cotransporter NaPi2b. Hybridoma 2008; 27: 277-84.
29. Gryshkova V, Goncharuk I, Gurtovyy V, et al. The study of phosphate transporter NaPi2b expression in different histological types of epithelial ovarian cancer. Exp Oncol 2009; 31: 1-6.
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9. (Pubitemid 17064313)
31. Kubista M, Andrade JM, Bengtsson M, et al. The real-time polymerase chain reaction. Mol Aspects Med 2006; 27: 95-125.
32. Xu H, Bai L, Collins JF, et al. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)2 vitamin D3. Am J Physiol Cell Physiol 2002; 282: 487-93.